Document Detail


Antiviral effect of ribonuclease conjugated oligodeoxynucleotides targeting the IRES RNA of the hepatitis C virus.
MedLine Citation:
PMID:  19450979     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Hepatitis C virus (HCV) translation initiation is mediated by a highly structured and conserved RNA, termed the Internal Ribosome Entry Site (IRES), located at the 5'-end of its single stranded RNA genome. It is a key target for the development of new antiviral compounds. Here we made use of the recently developed HCV cell culture system to test the antiviral activity of artificial ribonucleases consisting of imidazole(s) linked to antisense oligodeoxynucleotides targeting the HCV IRES. Results from the cell culture model indicate that the naked antisense oligodeoxynucleotide displayed an efficient antiviral activity. Despite the increased activity observed with the addition of imidazole moieties when tested with the cell-free system, it appears that these improvements were not reproduced in the cellular model.
Authors:
Carly Gamble; Maud Trotard; Jacques Le Seyec; Valérie Abreu-Guerniou; Nicolas Gernigon; Fabienne Berrée; Bertrand Carboni; Brice Felden; Reynald Gillet
Related Documents :
15914849 - Chimeric monoclonal antibodies to hypervariable region 1 of hepatitis c virus.
11059869 - The effects of the conserved extreme 3' end sequence of hepatitis c virus (hcv) rna on ...
20044809 - The heme oxygenase 1 product biliverdin interferes with hepatitis c virus replication b...
21725249 - Couple-based hiv prevention for low-income drug users from new york city: a randomized ...
16008349 - Specific targeting of hepatitis c virus ns3 rna helicase. discovery of the potent and s...
25177689 - The association of toll-like receptor 4 polymorphism with hepatitis c virus infection i...
21645259 - The impact of il28b genetic variants on recurrent hepatitis c in liver transplantation:...
21595969 - A hepatitis a, b, c and hiv prevalence and risk factor study in ever injecting and non-...
22985479 - Creating genetic resistance to hiv.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-05-04
Journal Detail:
Title:  Bioorganic & medicinal chemistry letters     Volume:  19     ISSN:  1464-3405     ISO Abbreviation:  Bioorg. Med. Chem. Lett.     Publication Date:  2009 Jul 
Date Detail:
Created Date:  2009-06-09     Completed Date:  2009-09-01     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9107377     Medline TA:  Bioorg Med Chem Lett     Country:  England    
Other Details:
Languages:  eng     Pagination:  3581-5     Citation Subset:  IM    
Affiliation:
Université de Rennes 1, UPRES JE 2311, INSERM U835, Biochimie Pharmaceutique, 2, Avenue du Prof. Léon Bernard, 35043 Rennes, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
5' Untranslated Regions / genetics
Antiviral Agents / chemistry,  pharmacology*
Base Sequence
Cell Line
Cell-Free System
Hepacivirus / drug effects*
Humans
Imidazoles / chemistry,  pharmacology*
Oligodeoxyribonucleotides / chemistry,  pharmacology*
Oligodeoxyribonucleotides, Antisense / chemistry,  metabolism,  pharmacology*
RNA, Viral / chemistry,  drug effects*,  metabolism
Chemical
Reg. No./Substance:
0/5' Untranslated Regions; 0/5' bis-imidazole AS-ODN; 0/Antiviral Agents; 0/Imidazoles; 0/Oligodeoxyribonucleotides; 0/Oligodeoxyribonucleotides, Antisense; 0/RNA, Viral; 288-32-4/imidazole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cometabolic biodegradation of 4-chlorophenol by sequencing batch reactors at different temperatures.
Next Document:  Discovery and structure-guided drug design of inhibitors of 11beta-hydroxysteroid-dehydrogenase type...